TG Therapeutics (TGTX) Reports Q4 Loss of $0.48/Share
TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.